Dr. Luis Villacorta's lab focuses on finding new, non-hormonal treatments for endometriosis, a painful condition affecting many women. The research aims to develop drugs that target specific pathways involved in inflammation and fibrosis associated with the disease, using novel compounds derived from nitro-fatty acids. The work combines basic science and preclinical models to test these potential new therapies, which could offer better options for managing endometriosis without the side effects of traditional hormonal treatments.